Health and Science

Shire and Takeda to announce preliminary deal Wednesday after breakthrough in merger talks: Reuters, citing sources

Key Points
  • London-listed drugmaker Shire and Japan's Takeda Pharmaceutical plan to announce a preliminary deal on Wednesday.
  • Takeda sweetened its $62 billion acquisition offer and Shire is expected to agree to an extension of a regulatory deadline that would allow Takeda to firm up its bid.
VIDEO0:3900:39
Shire, Takeda reach breakthrough in merger talks, says Reuters

London-listed drugmaker Shire and Japan's Takeda Pharmaceutical plan to announce a preliminary deal on Wednesday, after the latter sweetened its $62 billion acquisition offer, people familiar with the matter said.

Shire is also expected to agree to an extension of a Wednesday regulatory deadline that would allow Takeda to carry out more due diligence and firm up its bid, the sources said on Tuesday on condition of anonymity to discuss the confidential negotiations.

Takeda and Shire did not immediately respond to CNBC's request for comment.

--CNBC's Chloe Aiello contributed to this report.